Stockholders’ Equity - Schedule of Common Stock Reserved for Future Issuance (Details) - shares shares in Thousands |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
| Warrants outstanding (in shares) | 9,712 | |
| Stock options outstanding (in shares) | 2,649 | 2,651 |
| Total common stock reserved for future issuance (in shares) | 35,349 | |
| 2026 Equity Incentive Plan | ||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
| Shares reserved for future issuance (in shares) | 18,943 | |
| Total common stock reserved for future issuance (in shares) | 18,943 | |
| 2021 ESPP | ||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
| Shares reserved for future issuance (in shares) | 718 | |
| Restricted stock units ("RSUs") | ||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
| RSUs outstanding (in shares) | 3,327 | 897 |
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Aggregate number of common shares reserved for future issuance. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|